Side-by-side comparison of AI visibility scores, market position, and capabilities
Vertical farming pioneer; emerged from Chapter 11 bankruptcy in 2023, now profitable in microgreens with ~70% US retail market share in that category.
AeroFarms is a Newark, New Jersey-based vertical farming company founded in 2004 by David Rosenberg and Marc Oshima. The company pioneered aeroponic growing technology — delivering nutrients as a fine mist to plant roots suspended in the air — enabling highly efficient indoor crop production without soil or sunlight. AeroFarms built some of the world's largest indoor vertical farms before filing for Chapter 11 bankruptcy protection in 2023 following overexpansion and rising energy costs.\n\nAfter restructuring, the reorganized AeroFarms abandoned multi-facility expansion plans and focused operations on a single flagship facility. Crucially, the company pivoted its product focus from commodity salad greens to premium microgreens, where it now controls approximately 70% of the US retail market. This focused strategy enabled AeroFarms to achieve profitability — a remarkable turnaround that has become a case study in CEA operational discipline.\n\nAeroFarms' aeroponic technology platform remains at the cutting edge of controlled environment agriculture, and the company continues to license its IP and provide consulting services to third-party operators. Its survival and profitability post-bankruptcy stand in stark contrast to peers like Bowery Farming and Plenty, which ceased operations or filed for liquidation.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.